FUJIFILM Holdings Corporation Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016; Provides Earnings Guidance for the Year Ending March 31, 2017
January 31, 2017 at 03:00 pm
Share
FUJIFILM Holdings Corporation reported consolidated earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company reported revenue of ¥581,967 million against ¥615,426 million a year ago. Operating income was ¥50,667 million against ¥53,249 million a year ago. Income before income taxes was ¥65,562 million against ¥57,143 million a year ago. Net income was ¥46,829 million against ¥41,952 million a year ago. Net income attributable to company was ¥43,384 million against ¥37,438 million a year ago.
For the nine months, the company reported revenue of ¥1,702,904 million against ¥1,841,490 million a year ago. Operating income was ¥114,139 million against ¥133,920 million a year ago. Income before income taxes was ¥126,162 million against ¥141,742 million a year ago. Net income was ¥87,162 million against ¥97,654 million a year ago. Net income attributable to company was ¥76,928 million or ¥171.90 per diluted share against ¥84,384 million or ¥178.95 per diluted share a year ago. Net cash provided by operating activities was ¥189,989 million against ¥143,752 million a year ago. Purchases of property, plant and equipment was ¥55,469 million against ¥46,212 million a year ago.
For the year ending March 31, 2017, the company expected revenue of ¥2,400,000 million, operating income of ¥192,000 million, income before income taxes of ¥192,000 million, net income attributable to company of ¥112,000 million or ¥252.51 per share.
Fujifilm Holdings Corporation specializes in the manufacturing and marketing of printing, imaging and photography materials and equipment. Net sales break down by activity as follows:
- sale of printers and photocopiers (42.7%);
- sale of medical imaging equipment (41.4%): digital endoscopes, digital mammography devices, radiologic tables, ultrasound scan systems, etc. The group also develops pharmaceutical products development (generic drugs, health products, etc.) and design of graphic arts materials activities;
- sale of photography equipment (15.9%): digital cameras, bridges, lens, color negative films, films development materials, etc.
Net sales are distributed geographically as follows: Japan (48.7%), Americas (18.7%), Europe (10.1%) and other (22.5%).
FUJIFILM Holdings Corporation Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016; Provides Earnings Guidance for the Year Ending March 31, 2017